 | Up a level |
van den Bent, Martin J; Baumert, Brigitta; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Baurain, Jean Francais; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Brachman, David G; Taal, Walter; Rudà, Roberta; Weller, Michael; McBain, Catherine; Reijneveld, Jaap; ... (2017). Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet, 390(10103), pp. 1645-1653. Elsevier 10.1016/S0140-6736(17)31442-3
Murat, Anastasia; Migliavacca, Eugenia; Gorlia, Thierry; Lambiv, Wanyu L; Shay, Tal; Hamou, Marie-France; de Tribolet, Nicolas; Regli, Luca; Wick, Wolfgang; Kouwenhoven, Mathilde C M; Hainfellner, Johannes A; Heppner, Frank L; Dietrich, Pierre-Yves; Zimmer, Yitzhak; Cairncross, J Gregory; Janzer, Robert-Charles; Domany, Eytan; Delorenzi, Mauro; Stupp, Roger and Hegi, Monika E (2008). Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. Journal of clinical oncology, 26(18), pp. 3015-24. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.15.7164
Mirimanoff, René-Olivier; Gorlia, Thierry; Mason, Warren; Van den Bent, Martin J; Kortmann, Rolf-Dieter; Fisher, Barbara; Reni, Michele; Brandes, Alba A; Curschmann, Jüergen; Villa, Salvador; Cairncross, Gregory; Allgeier, Anouk; Lacombe, Denis; Stupp, Roger (2006). Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. Journal of clinical oncology, 24(16), pp. 2563-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5963
